These intronic SNPs in the SDC4 and ATM genes may, therefore, disrupt or suppress the binding or function of pathways such as the PI3K/AKT pathway, altering gene expression and increasing the risk of BC development. This evidence concerns the gene AKT1 and breast cancer.